Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma

被引:3
作者
Li, Xiumei [1 ]
Chen, Jianwei [2 ]
Zhang, Chengxiu [3 ]
Han, Zewen [1 ]
Zheng, Xiuying [1 ]
Cao, Dairong [1 ,4 ,5 ,6 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou 350014, Fujian, Peoples R China
[3] East China Normal Univ, Sch Phys & Elect Sci, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Dept Radiol, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[5] Fujian Med Univ, Affiliated Hosp 1, Fujian Key Lab Precis Med Canc, Fuzhou 350005, Fujian, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Key Lab Radiat Biol, Fujian Higher Educ Inst, Fuzhou 200062, Peoples R China
关键词
Lung adenocarcinoma; Radiomics; Computed tomography; T790M; CANCER;
D O I
10.1186/s12890-023-02609-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundThe purpose of this study was to develop a radiomic nomogram to predict T790M mutation of lung adenocarcinoma base on non-enhanced CT lung images.MethodsThis retrospective study reviewed demographic data and lung CT images of 215 lung adenocarcinoma patients with T790M gene test results. 215 patients (including 52 positive) were divided into a training set (n = 150, 36 positive) and an independent test set (n = 65, 16 positive). Multivariate logistic regression was used to select demographic data and CT semantic features to build clinical model. We extracted quantitative features from the volume of interest (VOI) of the lesion, and developed the radiomic model with different feature selection algorithms and classifiers. The models were trained by a 5-fold cross validation strategy on the training set and assessed on the test set. ROC was used to estimate the performance of the clinical model, radiomic model, and merged nomogram.ResultsThree demographic features (gender, smoking, emphysema) and ten radiomic features (Kruskal-Wallis as selection algorithm, LASSO Logistic Regression as classifier) were determined to build the models. The AUC of the clinical model, radiomic model, and nomogram in the test set were 0.742(95%CI, 0.619-0.843), 0.810(95%CI, 0.696-0.907), 0.841(95%CI, 0.743-0.938), respectively. The predictive efficacy of the nomogram was better than the clinical model (p = 0.042). The nomogram predicted T790M mutation with cutoff value was 0.69 and the score was above 130.ConclusionThe nomogram developed in this study is a non-invasive, convenient, and economical method for predicting T790M mutation of lung adenocarcinoma, which has a good prospect for clinical application.
引用
收藏
页数:11
相关论文
共 25 条
[11]   Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas [J].
Liu, Ying ;
Kim, Jongphil ;
Balagurunathan, Yoganand ;
Li, Qian ;
Garcia, Alberto L. ;
Stringfield, Olya ;
Ye, Zhaoxiang ;
Gillies, Robert J. .
CLINICAL LUNG CANCER, 2016, 17 (05) :441-448
[12]   Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study [J].
Minari, Roberta ;
Mazzaschi, Giulia ;
Bordi, Paola ;
Gnetti, Letizia ;
Alberti, Giorgia ;
Altimari, Annalisa ;
Gruppioni, Elisa ;
Sperandi, Francesca ;
Parisi, Claudia ;
Guaitoli, Giorgia ;
Bettelli, Stefania ;
Longo, Lucia ;
Bertolini, Federica ;
Pagano, Maria ;
Bonelli, Candida ;
Tagliavini, Elena ;
Nicoli, Davide ;
Ubiali, Alessandro ;
Zangrandi, Adriano ;
Trubini, Serena ;
Proietto, Manuela ;
Fiorentino, Michelangelo ;
Tiseo, Marcello .
CLINICAL LUNG CANCER, 2020, 21 (05) :E464-E473
[13]   Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation [J].
Oya, Yuko ;
Yoshida, Tatsuya ;
Kuroda, Hiroaki ;
Shimizu, Junichi ;
Horio, Yoshitsugu ;
Sakao, Yukinori ;
Inaba, Yoshitaka ;
Hida, Toyoaki ;
Yatabe, Yasushi .
CLINICAL LUNG CANCER, 2017, 18 (06) :698-+
[14]   Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitors [J].
Reguart, Noemi ;
Remon, Jordi .
FUTURE ONCOLOGY, 2015, 11 (08) :1245-1257
[15]   A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) [J].
Shi, Yuankai ;
Au, Joseph Siu-Kie ;
Thongprasert, Sumitra ;
Srinivasan, Sankar ;
Tsai, Chun-Ming ;
Khoa, Mai Trong ;
Heeroma, Karin ;
Itoh, Yohji ;
Cornelio, Gerardo ;
Yang, Pan-Chyr .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) :154-162
[16]   Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer [J].
Song, Jiangdian ;
Wang, Lu ;
Ng, Nathan Norton ;
Zhao, Mingfang ;
Shi, Jingyun ;
Wu, Ning ;
Li, Weimin ;
Liu, Zaiyi ;
Yeom, Kristen W. ;
Tian, Jie .
JAMA NETWORK OPEN, 2020, 3 (12)
[17]   Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients [J].
Song, Lan ;
Zhu, Zhenchen ;
Mao, Li ;
Li, Xiuli ;
Han, Wei ;
Du, Huayang ;
Wu, Huanwen ;
Song, Wei ;
Jin, Zhengyu .
FRONTIERS IN ONCOLOGY, 2020, 10
[18]   FeAture Explorer (FAE): A tool for developing and comparing radiomics models [J].
Song, Yang ;
Zhang, Jing ;
Zhang, Yu-Dong ;
Hou, Ying ;
Yan, Xu ;
Wang, Yida ;
Zhou, Minxiong ;
Yao, Ye-Feng ;
Yang, Guang .
PLOS ONE, 2020, 15 (08)
[19]   Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment [J].
Tang, Xin ;
Li, Yuan ;
Yan, Wei-feng ;
Qian, Wen-lei ;
Pang, Tong ;
Gong, You-ling ;
Yang, Zhi-gang .
FRONTIERS IN ONCOLOGY, 2021, 11
[20]   Epidemiology of lung cancer [J].
Thandra, Krishna Chaitanya ;
Barsouk, Adam ;
Saginala, Kalyan ;
Aluru, John Sukumar ;
Barsouk, Alexander .
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2021, 25 (01) :45-52